Investigators evaluated the long-term neurological, neurocognitive, social, and quality of life outcomes associated with posterior fossa syndrome among survivors of medulloblastoma.
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study Four independent nonoverlapping retrospective cohorts of posterior fossa ependymomas (n = 820) were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results